-
Signature
-
/s/ Lynn M. Cilinski, Attorney-in-fact
-
Stock symbol
-
MGNX
-
Transactions as of
-
Feb 5, 2024
-
Transactions value $
-
-$410,786
-
Form type
-
4
-
Date filed
-
2/7/2024, 04:17 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MGNX |
Common Stock |
Options Exercise |
$625K |
+54.4K |
|
$11.50 |
54.4K |
Feb 5, 2024 |
Direct |
|
transaction |
MGNX |
Common Stock |
Options Exercise |
$222K |
+21.9K |
+40.23% |
$10.15 |
76.3K |
Feb 5, 2024 |
Direct |
|
transaction |
MGNX |
Common Stock |
Sale |
-$897K |
-54.4K |
-71.31% |
$16.50 |
21.9K |
Feb 5, 2024 |
Direct |
F1 |
transaction |
MGNX |
Common Stock |
Sale |
-$361K |
-21.9K |
-100% |
$16.50 |
0 |
Feb 5, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MGNX |
Employee stock option (right to buy) |
Options Exercise |
$0 |
-54.4K |
-83.33% |
$0.00 |
10.9K |
Feb 5, 2024 |
Common Stock |
54.4K |
$11.50 |
Direct |
F2 |
transaction |
MGNX |
Employee stock option (right to buy) |
Options Exercise |
$0 |
-21.9K |
-31.25% |
$0.00 |
48.1K |
Feb 5, 2024 |
Common Stock |
21.9K |
$10.15 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: